Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1983 Oct-Dec;1(4):373-80.
doi: 10.1007/BF00121199.

TS/A: a new metastasizing cell line from a BALB/c spontaneous mammary adenocarcinoma

TS/A: a new metastasizing cell line from a BALB/c spontaneous mammary adenocarcinoma

P Nanni et al. Clin Exp Metastasis. 1983 Oct-Dec.

Abstract

A metastasizing mouse cell line (TS/A), originated from a mammary adenocarcinoma which arose spontaneously in a BALB/c female retired breeder, has been established in vitro. It displayed a remarkable morphologic heterogeneity, which is evident in plastic adherent cultures (cell types ranging from epithelial-like to fibroblast-like) as well as in semi-solid agar cultures. The TS/A line exhibited the presence of specific cytoplasmic estradiol receptor, with a binding activity of 16 fmoles/mg cytosol protein. The in vivo growth pattern was as follows: a s.c. inoculum of 105 cells caused a 100 per cent tumor take and kill in syngeneic animals; mean survival time was 54 +/- 1 days; it did not show significant transplant immunogenicity in syngeneic animals; it was able to give rise to both spontaneous lung metastases and artificial lung colonies; it had a high capacity to grow in H-2 matched, minor histocompatibility antigen incompatible hosts (10(6) cells killed 100 per cent DBA/2 mice in 58 +/- 2 days). This line of spontaneous mammary tumor cells is proposed as a useful model for studies on the heterogeneity of the neoplastic population in relation to metastatic spread, on tumor immunogenicity, and on therapy of mammary neoplasia.

PubMed Disclaimer

References

    1. Exp Cell Res. 1977 Feb;104(2):255-62 - PubMed
    1. J Biol Response Mod. 1983;2(3):210-6 - PubMed
    1. Br J Cancer. 1981 Oct;44(4):588-91 - PubMed
    1. Br J Cancer. 1976 Mar;33(3):241-59 - PubMed
    1. Eur J Immunol. 1976 Jul;6(7):473-6 - PubMed

Publication types

Substances